Contact IMV

IMV Executive Assistant


tel. (612) 624-1926

fax. (612) 625-1108


18-242 Moos Tower
515 Delaware St. SE
Minneapolis, MN 55455

General Questions:

Jason Baker,
Assistant Professor

Clinical Management of HIV Infection



BS, MD University of Wisconsin-Madison

MS University of Minnesota, Clinical Research

Research Interests

The pathogenosis of cardiovascular disease in HIV-infected patients, as well as the evaluation of prevention strategies of these patients.

Selected Recent Publications

  • Baker JV, Peng G, Rapkin J, Abrams D, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD for the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). CD4+ cell count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008;22(7):841-848. (PMID: 18427202)

  • Baker JV, Ayenew W, Quick H, Huppler Hullsiek K, Tracy R, Henry K, Duprez D, Neaton JD. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. Journal of Infectious Diseases 2010;201(2):285-292 (PMID: 19954384; PMC2798007)

  • Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett S, Ristola M, Ross MJ, Shlipak MG, Tracy R, and Neaton JD for the INSIGHT SMART, MESA and CARDIA Research Groups. Markers of inflammation, coagulation and renal function in adults with HIV infection and in two population based cohorts. Journal of Infectious Diseases 2010;201(12):1788-95 (PMID: 20446848; PMC 3005856)

  • Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy RP, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, and Neaton JD for the INSIGHT SMART Study Group. Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate Versus Deferred Antiretroviral Therapy in Patients with HIV Infection. Journal of AIDS 2011;56(1):36-43 (PMID 20930640)

  • Baker JV and Henry K. If we can't get what we want, can we get what we need? -- optimizing use of antiretroviral therapy in the current era (editorial). Annals of Internal Medicine 2011;154:563-5

  • Baker JV and Lundgren J. Cardiovascular Implications of Untreated HIV Infections. European Heart Journal 2011;32(8):945-51.

  • Baker JV, Henry WK, Patel P, Bush TJ, Conley LJ, Mack WJ, Overton ET, Budoff M, Hammer J, Carpenter CC, Hodis HN, Brooks JT for the SUN Study Investigators. Progression of Carotid Intima-Media Thickness in a Contemporary HIV Cohort. Clinical Infectious Diseases 2011.

  • Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy RP, Neaton JN for the INSIGHT SMART Study Group. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS 2011



Featured News & Events

'Wisc-e-sota', a Joint UMN-UW Virology Training Grant Symposium was first held on Friday, Sepbember 20th, 2013 at the Uniiversity of Wisconsin-La Crosse, Cartwright Center. This was the inaugural collaborative symposium of the NIH T32-supported virology training programs at the University of Wisconsin-Madison and the University of Minnesota-Twin Cities. Talks and poster sessions were presented by students, postdocs and faculty. The second UMN-UW Virology Training Grant Symposium will be held in the Fall 2014. Details to follow.

The 2014 IMV Symposium will be held on May 12, 2014 and Mark Denison (Vanderbilt) and Bert Semler (UC-Irvine) will be the Keynote Speakers. Click on the link below to register and submit abstracts.

About the IMV icon

Read about bacteriophage phi 29 and why it matters.

IMV Timeline

Explore nearly a century's worth of discovery in the field of virology at the University of Minnesota.


"This Week in Virology" from professor Vincent Racaniello.